USE OF A COMPUTER-GUIDED GLUCOSE MANAGEMENT SYSTEM TO IMPROVE GLYCEMIC CONTROL AND ADDRESS NATIONAL QUALITY MEASURES: A 7-YEAR, RETROSPECTIVE OBSERVATIONAL STUDY AT A TERTIARY CARE TEACHING HOSPITAL

Objective: Inpatient hyperglycemia, hypoglycemia, and glucose variability are associated with increased mortality. The use of an electronic glucose management system (eGMS) to guide intravenous (IV) insulin infusion has been found to significantly improve blood glucose (BG) control. This retrospective observational study evaluated the 7-year (January 2009-December 2015) impact of the EndoTool (R) eGMS in intensive and intermediate units at Vidant Medical Center, a 900-bed tertiary teaching hospital. Methods: Patients assigned to eGMS had indications for IV insulin infusion, including uncontrolled diabetes, stress hyperglycemia, and/or postoperative BG levels > 140 mg/dL. This study evaluated time required to achieve BG control (< 180 mg/dL; < 140 mg/dL for cardiovascular surgery patients); hypoglycemia incidence (< 70 and < 40 mg/dL); glucose variability (assessed by SD and coefficient of variation percentage [CV%]); excursions (BG levels > 180 mg/dL after control attained); and the impact of eGMS on hospital-acquired condition (HAC)-8 rates. Results: Data were available for all treated patients (492,078 BG readings from 16,850 patients). With eGMS, BG levels were brought to target within 1.5 to 2.3 hours (4.5 to 4.8 hours for cardiovascular patients). Minimal hypoglycemia was observed (BG values < 70 mg/dL, 0.93%; < 40 mg/dL, 0.03%), and analysis of variance of BG values < 70 mg/dL showed significant reductions over time in hypoglycemia frequency, from 1.04% in 2009 to 0.46% in 2015 (P<. 0001). The CV% per patient visit was 26.5 (+/- 12.9)%, and 4% of patients experienced glucose excursions (defined as BG levels > 180 mg/dL once control was attained). HAC-8 rates were reduced from 0.083 per 1,000 patients (2008) to 0.032 per 1,000 patients (2011). Conclusion: The use of eGMS resulted in rapid, effective control of inpatient BG levels, including significantly reduced hypoglycemia rates.